Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
June 03, 2013 at 13:41 PM EDT
Afternoon Market Losers
Synta Pharmaceuticals (NASDAQ: SNTA ) is down 32.32% to $4.99 after Synta reported positive overall survival results from GALAXY-1 Phase 2b/3 trial of Ganetespib in second-line non-small cell lung cancer. Infinity Pharmaceuticals (NASDAQ: INFI ) dropped 26.10% to 19.92 on Phase 1 data. Affymax (NASDAQ: AFFY ) dropped 19.23%
Read More >>
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial
Bots go here